Target Name: MIR4453HG
NCBI ID: G54553
Review Report on MIR4453HG Target / Biomarker Content of Review Report on MIR4453HG Target / Biomarker
MIR4453HG
Other Name(s): LINC02486 | DKFZP434I0714 | MIR4453 host gene

MIR4453HG: A Potential Drug Target and Biomarker

Molecular Targets

MIR4453HG is a potential drug target and biomarker that has been identified in various diseases, including cancer. It is a non-coding RNA molecule that is expressed in various tissues and cells, including the brain, heart, and testes. MIR4453HG has been shown to play a role in the development and progression of various diseases, including cancer.

Disease-Related Signatures

MIR4453HG has been shown to be involved in several diseases, including cancer. Studies have shown that MIR4453HG is overexpressed in various cancer types, including breast, ovarian, and prostate cancers. This overexpression is associated with a poor prognosis for the patients.

In addition to its involvement in cancer, MIR4453HG has also been linked to several other diseases. For example, it has been shown to be overexpressed in individuals with Alzheimer's disease, a condition that is characterized by progressive memory loss and cognitive decline.

Biomarker Potential

MIR4453HG has the potential to serve as a biomarker for several diseases, including cancer. Its overexpression in cancer cells makes it a potential target for anti-cancer drugs. Additionally, its levels have been shown to be elevated in individuals with certain diseases, which could make it an potential biomarker for these conditions.

Molecular Mechanisms

MIR4453HG is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression. It is expressed in various tissues and cells, including the brain, heart, and testes. Studies have shown that MIR4453HG can interact with other non-coding RNAs, including let-78, a protein that has been shown to play a role in the regulation of gene expression.

In addition to its role in gene regulation, MIR4453HG has also been shown to play a role in the regulation of microRNA (miRNA) expression. miRNA is a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. Studies have shown that MIR4453HG can interact with miRNAs, including miR-18a, a miRNA that has been shown to play a role in the regulation of cell growth and apoptosis.

The Potential Role of MIR4453HG in Cancer

MIR4453HG has been shown to play a role in the development and progression of several cancers, including breast, ovarian, and prostate cancers. Its overexpression in these cancers is associated with a poor prognosis for the patients.

In addition to its role in cancer, MIR4453HG has also been shown to contribute to the development of several other diseases, including Alzheimer's disease. Its overexpression in individuals with Alzheimer's disease is associated with the progressive memory loss and cognitive decline that is characteristic of this condition.

MIR4453HG as a Drug Target

MIR4453HG has the potential to serve as a drug target for several diseases, including cancer. Its overexpression in cancer cells makes it a potential target for anti-cancer drugs. Additionally, its levels have been shown to be elevated in individuals with certain diseases, which could make it an potential biomarker for these conditions.

MIR4453HG has been shown to interact with several protein

Protein Name: MIR4453 Host Gene

The "MIR4453HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4453HG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647